Tate & Lyle PLC
26 November 2004 - Tate & Lyle PLC
Director Shareholding
Tate & Lyle PLC (the 'Company') was informed on 26 November 2004 that the
following share transactions were completed by Directors of the Company:
i) On 25 November 2004, Mr Stuart Strathdee, an Executive Director of the
Company, exercised options under the Tate & Lyle 2000 Executive Share Option
Scheme at 286 pence per share over 89,160 ordinary shares in the Company
('shares'). He subsequently sold 67,512 shares at 490 pence per share to pay the
subscription price, tax and National Insurance, and retained the remaining
21,648 shares. Following this transaction, Mr Strathdee now has an interest in
73,062 shares in the Company.
ii) On 26 November 2004, Mr Simon Gifford, an Executive Director of the Company,
exercised options under the Tate & Lyle 1992 Executive Share Option Scheme at
425 pence per share over 4,000 shares in the Company.
All 4,000 shares were retained following the exercise of the options. Following
this transaction, Mr Gifford now has an interest in 79,014 shares in the
Company.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.